-
2018-05-31TaiwanJ will join 2018 BioTaiwan Exhibition
TaiwanJ will join 2018 BioTaiwan Exhibition. Our exhibit venue is at Taipei World Trade Center- Nangang Exhibition Hall 4F. We look forward to your visit. Exhibit Date: July 19th (Thu) ~July ... -
2018-04-13The phase 2 clinical trial result of JKB-121 for NASH has been presented at International Liver Congress™ 2018.
今年度(2018)國際肝病大會預計於4月11日至14日於法國巴黎舉辦，景凱生技的JKB-121用於治療NASH的臨床試驗二期結果，受到歐洲肝病協會青睞，被邀請於2018年的年會進行口頭報告，且此報告亦獲大會授予最佳簡報榮譽。 ... -
2017-09-20TaiwanJ Pharmaceuticals unveiled first-stage unblinding of Phase II clinical trials in chronic liver disease (CLD) due to HCV infection
TaiwanJ Pharmaceuticals is a discovery-based drug company focused on research and development of novel ‘antiinflammatory and immunomodulating’ agents with blockbuster potential. Its ... -
2017-06-08TaiwanJ will join 2017 BioTaiwan Exhibition
TaiwanJ will join 2017 BioTaiwan Exhibition. Our exhibit venue is at Taipei World Trade Center- Nangang Exhibition Hall 4F. You will receive a gift for joining TaiwanJ Facebook’s Fan Page at exh...
